Journey Medical (DERM) grants director 50,000 restricted stock units

Rhea-AI Filing Summary

Herskowitz Neil reported acquisition or exercise transactions in this Form 4 filing.

Journey Medical Corp director Neil Herskowitz received a grant of 50,000 restricted stock units (RSUs) of common stock as equity compensation. The grant was made on July 1, 2026 under the company’s 2015 Stock Plan and will vest over several years.

The RSUs vest in three tranches: 16,666 shares on July 1, 2029, 16,667 shares on July 1, 2030, and 16,667 shares on July 1, 2031, if applicable conditions are met. After this award, Herskowitz’s direct holdings, including RSUs that vest over time, total 168,618 shares.

Insider Trade Summary

1 transaction reported

Mixed 1 txn

Insider Herskowitz Neil

Role null

Type	Security	Shares	Price	Value
Grant/Award	Common Stock, $0.0001 par value	50,000	$0.00	--

Holdings After Transaction: Common Stock, $0.0001 par value — 168,618 shares (Direct, null)

Footnotes (1)

1. On July 1, 2026, the reporting person was granted 50,000 restricted stock units pursuant to the Issuer's 2015 Stock Plan, as amended, which will vest in accordance with the following schedule: 16,666 shares on July 1, 2029, 16,667 shares on July 1, 2030 and 16,667 shares on July 1, 2031. Includes restricted stock units, which vest over various time periods.

Key Figures

RSUs granted: 50,000 shares Vesting tranche 1: 16,666 shares Vesting tranche 2: 16,667 shares +3 more

6 metrics

RSUs granted 50,000 shares Restricted stock units granted on July 1, 2026

Vesting tranche 1 16,666 shares RSUs vesting on July 1, 2029

Vesting tranche 2 16,667 shares RSUs vesting on July 1, 2030

Vesting tranche 3 16,667 shares RSUs vesting on July 1, 2031

Holdings after transaction 168,618 shares Total direct holdings after RSU award

Grant price per share $0.0000 Form 4 transaction price field for RSU grant

Key Terms

restricted stock units, 2015 Stock Plan, vest, beneficial ownership

4 terms

restricted stock units financial

"the reporting person was granted 50,000 restricted stock units pursuant to the Issuer's 2015 Stock Plan"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

2015 Stock Plan financial

"granted 50,000 restricted stock units pursuant to the Issuer's 2015 Stock Plan, as amended"

vest financial

"which will vest in accordance with the following schedule: 16,666 shares on July 1, 2029"

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

beneficial ownership financial

"Includes restricted stock units, which vest over various time periods."

Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 07/02/2026 - 04:06 PM Accepted by SEC EDGAR 07/02/2026 - 04:05 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Herskowitz Neil

(Last) (First) (Middle)

C/O JOURNEY MEDICAL CORPORATION

9237 E VIA DE VENTURA BLVD., SUITE 105

(Street)

SCOTTSDALE ARIZONA 85258

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Journey Medical Corp [ DERM ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
07/01/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock, $0.0001 par value	07/01/2026		A		50,000(1)	A	$0	168,618(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. On July 1, 2026, the reporting person was granted 50,000 restricted stock units pursuant to the Issuer's 2015 Stock Plan, as amended, which will vest in accordance with the following schedule: 16,666 shares on July 1, 2029, 16,667 shares on July 1, 2030 and 16,667 shares on July 1, 2031.

2. Includes restricted stock units, which vest over various time periods.

	/s/ Ramsey Alloush, attorney-in-fact	07/02/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

FAQ

What did Journey Medical Corp (DERM) disclose about Neil Herskowitz in this Form 4?

Journey Medical Corp disclosed that director Neil Herskowitz received 50,000 restricted stock units of common stock on July 1, 2026. These RSUs were granted under the company’s 2015 Stock Plan as part of his equity compensation and will vest over multiple future dates.

How many Journey Medical (DERM) shares does Neil Herskowitz hold after this RSU grant?

After the RSU grant, Neil Herskowitz holds 168,618 Journey Medical shares directly, including restricted stock units that vest over various periods. This figure reflects his updated beneficial ownership as reported in the Form 4 following the July 1, 2026 equity award.

What are the vesting terms of the 50,000 RSUs granted to Journey Medical director Neil Herskowitz?

The 50,000 RSUs vest in three installments: 16,666 shares on July 1, 2029, 16,667 shares on July 1, 2030, and 16,667 shares on July 1, 2031. Vesting is scheduled over several years, rewarding longer-term service to Journey Medical Corp.

Under which plan were Neil Herskowitz’s Journey Medical RSUs granted?

The RSUs were granted under Journey Medical Corp’s 2015 Stock Plan, as amended. This plan governs equity awards such as restricted stock units to directors and other participants, aligning their compensation with long-term shareholder interests through stock-based incentives.

Does the Form 4 indicate open-market buying or selling by Neil Herskowitz of Journey Medical shares?

The Form 4 reflects an acquisition coded as a grant or award, not an open-market trade. Herskowitz received 50,000 restricted stock units at no stated purchase price, indicating a compensation-related equity award rather than discretionary buying or selling on the market.